Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.

American journal of industrial medicine - 1 Jun 2002

Weston Ainsley, Ensey James, Kreiss Kathleen, Keshava Channa, McCanlies Erin

Abstract excerpt

BACKGROUND: A beryllium materials manufacturer is conducting a limited pilot program that offers testing for HLA-DP beta 1E69 with genetic counseling through a third party to applicants for employment. An important consideration in this regard is the prevalence of this marker in the general popul...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Carrier Screening
Share to Hispanic or Latino
Share to HLA-DP Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pilot Projects

Share to Predictive Value of Tests

Share to Racial Groups

Share to Sensitivity and Specificity

Share to United States

Source

Identifiers

PMID: 12173370
DOI: 10.1002/ajim.10072

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12173370-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.PMID 12173370Read ↗

Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease.Semantic proximity Read ↗

Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.Semantic proximity Read ↗

HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.Semantic proximity Read ↗

Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.Semantic proximity Read ↗

HLA-DPB1 and chronic beryllium disease: a HuGE review.Semantic proximity Read ↗

Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.Semantic proximity Read ↗

The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.Semantic proximity Read ↗

Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.Semantic proximity Read ↗

HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.Semantic proximity Read ↗

Genome-wide association study and HLA genotyping for beryllium disease susceptibility in a European descent population.Semantic proximity Read ↗

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.Semantic proximity Read ↗

Genetic susceptibility to beryllium: a case-referent study of men and women of working age with sarcoidosis or other chronic lung disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.